DiaMedica Therapeutics Inc. DMAC

Full chart Compare
Set alert

Price alert · DMAC

All alert types
10.00 USD +0.71 (+7.64%)

At closeNov 4, 2026, 7:00 AM EST

10.13 +0.13 +1.30%

Pre-market · Nov 4, 7:00 AM ET

9.38 Day range 10.04
5.25 52-week range 10.42
YTD
+25.63%
1 year
+47.06%

Revenue & Expenses

Other Income → Expenses: $1.11MExpenses → Selling, General & Admin: $2.74MExpenses → Research & Development: $4.52MExpenses → Income Tax: $80.00KGross Profit → Expenses: $500.00KRevenue → Gross Profit: $500.00KNet Loss → Expenses: $5.73MOther Income$1.11MGross Profit$500.00KNet Loss$5.73MExpenses$7.34MSelling, General & Admin$2.74MResearch & Development$4.52MIncome Tax$80.00KRevenue$500.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

DMAC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-34.40M-26.68M-21.27M-14.00M-13.65M
-32.77M-24.44M-19.38M-13.70M-13.64M
-0.70-0.60-0.60-0.52-0.65
DMAC annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
15.65M3.02M4.54M4.73M4.71M
61.37M46.34M54.16M34.40M45.55M
5.26M5.63M3.10M2.57M1.53M
240.00K340.00K400.00K469.00K52.00K
56.11M40.72M51.06M31.83M44.02M
DMAC annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-29.06M-22.08M-18.73M-11.51M-12.25M
-2.19M8.56M-18.30M11.54M-20.54M
43.88M11.99M36.84M-6.00K30.09M
-40.00K-25.00K-24.00K-81.00K-20.00K
12.62M-1.52M-185.00K21.00K-2.70M